Based on the above proposal, we utilize hESC-derived islet organoids, animal models and COVID-19 patients to elucidate the effect of FGF7 on ACE2 levels within the islets, and its implications for insulin secretion and SARS-CoV-2 infection. The gene discussed is FGF7; the disease is COVID-19.